Inflammatory cytokines such as tumor necrosis factor (TNF) have been implicated in the pathogenesis of psoriasis. We evaluated the safety and efficacy of etanercept, a TNF antagonist, for the ...

Etanercept, a soluble tumor necrosis factor receptor, has been shown to lessen disease severity in adult patients with psoriasis. We assessed the efficacy and safety of etanercept in children and ...

Treatment with etanercept plus methotrexate has been shown to be effective in patients with rheumatoid arthritis (RA). Sulfasalazine is widely prescribed for the treatment of RA; however, it is not ...

Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug reaction characterized by widespread epidermal necrosis and detachment. It results in severe morbidity, with mortality rates of up to ...

The Assessment Report included 3 double-blind RCTs that evaluated etanercept at a dose of 25 mg or 50 mg twice a week. In total, 1,347 patients were enrolled in the RCTs. The Assessment Group deemed ...

Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Etanercept - Biosimilar Insight, 2024" report has been added to ResearchAndMarkets.com's offering. This "Etanercept - Biosimilar Insight, 2024" report ...

The US Food and Drug Administration (FDA) today approved etanercept-szzs (Erelzi, Sandoz), a biosimilar to etanercept (Enbrel, Amgen) for rheumatoid arthritis and other inflammatory diseases. The ...

Review the side-effects of Etanercept as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Both etanercept and ustekinumab have been shown to be strikingly effective in patients with psoriasis. A phase III trial comparing these two biologic agents for the treatment of moderate-to-severe ...

(HealthDay)—Treatment of rabbits with a partial spinal cord injury (SCI) with the intramuscularly-administered tumor necrosis factor-α (TNF-α) inhibitor etanercept is associated with improved clinical ...